CYP3A4 Substrate Selection and Substitution in the Prediction of Potential Drug-Drug Interactions
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.883 · Cited by 471
ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION
Isoherranen, N., Kunze, K. L., Allen, K. E., Nelson, W. L., & Thummel, K. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000315 · Cited by 276 · cited 1×
“…et al., 1997): afe 10 1/n log Predicted/Observed (4) mse 1 n Predicted Observed)2 (5) rmse mse (6) Of the three itraconazole metabolites reported by Isoherranen et al. (2004) (hydroxy-, keto- and N-desalkyl-itraconazole), only the contribution of hydroxy-itraconazole was included in the prediction.”
BackgroundItraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
Neuvonen, P. J., & Jalava, K.-M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90167-8 · Cited by 238 · cited 1×
“…1.15 1.5 1.5 1.5 1.5 0.37 Kantola et al. (1999) Lovastatin 8.6 3.9 4.6 4.3 2.7 0.90 Kivisto et al. (1998) Lovastatin 21.6 5.2 6.1 5.3 4.3 0.90 Neuvonen and Jalava (1996) Fluconazole Midazolam 3.6 2.8 1.8 2.6 1.15 0.99 Olkkola et al. (1996) Triazolam 1.6 1.5 1.2 1.4 1.02 0.98 Varhe et al.…”
InfluentialDifferent effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
Kivistö, K. T., Kantola, T., & Neuvonen, P. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00034.x · Cited by 171
Cited by
The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions
Obach, R. S., Walsky, R. L., Venkatakrishnan, K., Gaman, E. A., Houston, J. B., & Tremaine, L. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093229 · Cited by 433
Self-citationTerkeltaub, R. A. (2009) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.006 · Cited by 299
Zhang, D., Chando, T. J., Everett, D. W., Patten, C. J., Dehal, S. S., & Humphreys, W. G. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005447 · Cited by 286
Guest, E. J., Aarons, L., Houston, J. B., Rostami-Hodjegan, A., & Galetin, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036103 · Cited by 199
“This study considers the importance of the two-fold criterion in the assessment of DDI prediction success.”
BackgroundMethodSelf-citation
Metadata
- Authors
- Galetin, A., Ito, K., Hallifax, D., & Houston, J. B.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 314
- Issue
- 1
- Pages
- 180-190
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2116972576
- Cited by
- 158
- References
- 5
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.